Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Zelterman · SciRah

Researcher profile · Semantic Scholar

D. Zelterman

Share profile

D. Zelterman — researcher profile on SciRah

h-index: 53
Works: 235
Citations: 9,423

Most-cited papers

Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
S. Goldberg, Azeet Narayan, A. Kole, R. Decker +15 more
2018Clinical Cancer Research376 citations Open access
Semantic Scholar
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
K. Hastings, H.-A. Yu, W. Wei, F. Sanchez-Vega +27 more
2019Annals of Oncology330 citations Open access
Semantic Scholar
A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis
T. Paranjape, H. Heneghan, R. Lindner, F. Keane +16 more
2011The Lancet Oncology146 citations Open access
Semantic Scholar
Multiplex quantitative analysis of tumor-infiltrating lymphocytes and immunotherapy outcome in metastatic melanoma
P. Wong, Wei Wei, J. Smithy, Balasz Acs +5 more
2019Clinical Cancer Research122 citations Open access
Semantic Scholar
Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non–Small Cell Lung Cancer
S. Gettinger, A. Wurtz, S. Goldberg, D. Rimm +8 more
2018Journal of Thoracic Oncology120 citations Open access
Semantic Scholar
Human POLB Gene Is Mutated in High Percentage of Colorectal Tumors*
K. Donigan, Ka-wai Sun, Antonia A. Nemec, D. Murphy +4 more
2012Journal of Biological Chemistry95 citations Open access
Semantic Scholar
A KRAS-variant is a Biomarker of Poor Outcome, Platinum Chemotherapy Resistance and a Potential Target for Therapy in Ovarian Cancer
E. Ratner, F. Keane, R. Lindner, R. Tassi +25 more
2011Oncogene88 citations Open access
Semantic Scholar
A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non–Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1
S. Weiss, D. Djureinovic, S. Jessel, Irina Krykbaeva +18 more
2021Clinical Cancer Research87 citations Open access
Semantic Scholar
Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma
P. Wong, Wei Wei, Swati Gupta, J. Smithy +3 more
2019Journal of Immunotherapy for Cancer63 citations Open access
Semantic Scholar
Applied Linear Models with SAS: Contents
D. Zelterman
201063 citations
Semantic Scholar
Mutation of POL B Causes Lupus in Mice
A. Senejani, Yan-Feng Liu, D. Kidane, S. Maher +7 more
2014Cell Reports60 citations Open access
Semantic Scholar
The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma
A. Truini, J. Starrett, T. Stewart, Kumar D. Ashtekar +11 more
2019Clinical Cancer Research58 citations Open access
Semantic Scholar
Natural ventilation reduces high TB transmission risk in traditional homes in rural KwaZulu-Natal, South Africa
M. Lygizos, S. Shenoi, R. Brooks, Ambika Bhushan +6 more
2013BMC Infectious Diseases56 citations Open access
Semantic Scholar
AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers
M. Abu-Khalaf, K. A. Hodge, C. Hatzis, E. Baldelli +12 more
2023npj Precision Oncology44 citations Open access
Semantic Scholar
DNA polymerase beta participates in DNA End-joining
Sreerupa Ray, G. Breuer, M. Deveaux, D. Zelterman +2 more
2017Nucleic Acids Research44 citations Open access
Semantic Scholar
Clinical and serologic responses following a two dose series of high-dose influenza vaccine in plasma cell disorders: a prospective, single-arm trial
Andrew R. Branagan, Eamon Y. Duffy, R. Albrecht, D. Cooper +10 more
2017Clinical Lymphoma, Myeloma & Leukemia41 citations Open access
Semantic Scholar
Geographic poverty and racial/ethnic disparities in cervical cancer precursor rates in Connecticut, 2008-2009.
L. Niccolai, Pamela J. Julian, A. Bilinski, Niti R. Mehta +4 more
2013American Journal of Public Health36 citations Open access
Semantic Scholar
Should the 7th Edition of the Lung Cancer Stage Classification System Change Treatment Algorithms in Non-small Cell Lung Cancer?
D. Boffa, F. Detterbeck, Erica J. Smith, R. Rami-Porta +5 more
2010Journal of Thoracic Oncology36 citations Open access
Semantic Scholar
Rare BRCA1 haplotypes including 3’UTR SNPs associated with breast cancer risk
Cory Pelletier, W. C. Speed, T. Paranjape, K. Keane +8 more
2011Cell Cycle35 citations Open access
Semantic Scholar
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer
R. Pilarski, D. Patel, J. Weitzel, T. Mcveigh +11 more
2012PLoS ONE34 citations Open access
Semantic Scholar
Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors
Deborah Ayeni, Braden Miller, Alexandra Kuhlmann, Ping-Chih Ho +13 more
2018Journal of Immunotherapy for Cancer31 citations Open access
Semantic Scholar
Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy
C. Acevedo-Gadea, C. Hatzis, G. Chung, Neal Fishbach +5 more
2015Breast Cancer Research and Treatment25 citations
Semantic Scholar
A spatial simulation approach to account for protein structure when identifying non-random somatic mutations
Gregory A. Ryslik, Yu-Wei Cheng, Kei-Hoi Cheung, R. Bjornson +3 more
2013BMC Bioinformatics25 citations Open access
Semantic Scholar
WAG‐F8m1Ycb rats harboring a factor VIII gene mutation provide a new animal model for hemophilia A
C. Booth, M. Brooks, S. Rockwell, J. W. Murphy +5 more
2010Journal of Thrombosis and Haemostasis23 citations Open access
Semantic Scholar
DNA polymerase beta germline variant confers cellular response to cisplatin therapy
Antonia A. Nemec, L. Abriola, J. Merkel, E. de Stanchina +4 more
2017Molecular Cancer Research22 citations Open access
Semantic Scholar
Wide Variations in Blood Product Transfusion Practices among Providers Who Care for Patients with Acute Leukemia in the United States
Alexander B. Pine, Eun-Ju Lee, M. Sekeres, D. Steensma +16 more
2016Transfusion22 citations Open access
Semantic Scholar
Survival from XDR-TB Is Associated with Modifiable Clinical Characteristics in Rural South Africa
S. Shenoi, R. Brooks, R. Barbour, F. Altice +5 more
2012PLoS ONE20 citations Open access
Semantic Scholar
Comparative risks of non-prescription analgesics: a structured topic review and research priorities
E. Lavonas, J. Fries, D. Furst, K. Rothman +6 more
2012Expert Opinion on Drug Safety20 citations
Semantic Scholar
Methylation of Twelve CpGs in Human Papillomavirus Type 16 (HPV16) as an Informative Biomarker for the Triage of Women Positive for HPV16 Infection
J. Brandsma, M. Harigopal, Nancy B. Kiviat, Ying Sun +8 more
2014Cancer Prevention Research18 citations Open access
Semantic Scholar
Fructosamine reference ranges in rhesus macaques (Macaca mulatta).
Misty J. Williams-Fritze, Peter C. Smith, D. Zelterman, Jodi A. Carlson Scholz
2011Journal of the American Association for Laboratory Animal Science17 citations
Semantic Scholar
DNA Polymerase Beta is Critical for Genomic Stability of Sperm Cells
D. Kidane, S. Dalal, Agnes Keh, Yan-Feng Liu +2 more
2011DNA Repair16 citations Open access
Semantic Scholar
Impact of structural ageism on greater violence against older persons: a cross-national study of 56 countries
E. Chang, Joan K. Monin, D. Zelterman, B. Levy
2021BMJ Open15 citations Open access
Semantic Scholar
Beta Prime Regression with Application to Risky Behavior Frequency Screening
A. Tulupyev, A. Suvorova, J. Sousa, D. Zelterman
2013Statistics in Medicine15 citations Open access
Semantic Scholar
Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin–bound paclitaxel in patients with advanced solid tumors
M. Abu-Khalaf, M. Baumgart, S. Gettinger, I. Doddamane +12 more
2015Cancer14 citations Open access
Semantic Scholar
Estrogen withdrawal, increased breast cancer risk and the KRAS-variant
T. Mcveigh, Song-Yi Jung, M. Kerin, D. Salzman +15 more
2015Cell Cycle12 citations Open access
Semantic Scholar
Applied Linear Models with SAS: Review of Methods
D. Zelterman
201012 citations
Semantic Scholar
Accounting for Multiple Comparisons in Statistical Analysis of the Extensive Bioassay Data on Glyphosate.
K. Crump, E. Crouch, D. Zelterman, C. Crump +1 more
2020Toxicological Sciences11 citations
Semantic Scholar
A parametric model to estimate the proportion from true null using a distribution for p-values
Chang Yu, D. Zelterman
2017Computational Statistics & Data Analysis10 citations Open access
Semantic Scholar
Bayesian local exchangeability design for phase II basket trials
Yilin Liu, M. Kane, Denise A. Esserman, O. Bláha +2 more
2021Statistics in Medicine9 citations Open access
Semantic Scholar
A general approximation to quantiles
Yu Chang, D. Zelterman
2017Communications in statistics: theory and methods9 citations Open access
Semantic Scholar
The Use of Hypomethylating Agents (HMAs) in Patients with Relapsed and Refractory Acute Myeloid Leukemia (RR-AML): Clinical Outcomes and Their Predictors in a Large International Patient Cohort
M. Stahl, N. Podoltsev, M. Deveaux, S. Perreault +22 more
20168 citations
Semantic Scholar
Implicit and Explicit Dehumanization of Older Family Members: Novel Determinants of Elder Abuse Proclivity
E. Chang, Joan K. Monin, N. Isenberg, D. Zelterman +1 more
2022Stigma and Health7 citations Open access
Semantic Scholar
Testing Violations of the Exponential Assumption in Cancer Clinical Trials with Survival Endpoints
G. Han, Michael J. Schell, He-Ping Zhang, D. Zelterman +3 more
2016Biometrics7 citations Open access
Semantic Scholar
Multivariable Linear Regression
D. Zelterman
20156 citations
Semantic Scholar
A two-stage phase II clinical trial design with nested criteria for early stopping and efficacy
M. Deveaux, M. Kane, Wei Wei, D. Zelterman
2013Pharmaceutical statistics6 citations Open access
Semantic Scholar
Contingency Tables in Medical Studies
D. Zelterman, T. Louis
2019Medical Uses of Statistics5 citations
Semantic Scholar
Clinical Trial Design Using A Stopped Negative Binomial Distribution
M. Deveaux, M. Kane, D. Zelterman
2018Statistics and its Interface5 citations Open access
Semantic Scholar
MA15.06 Predictive Value of Measuring Somatic Mutations and Tumor Infiltrating Lymphocytes for PD-1 Axis Therapy in Non-Small Cell Lung Cancer (NSCLC)
S. Gettinger, Jungmin Choi, N. Mani, I. Datar +8 more
20175 citations Open access
Semantic Scholar
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial
P. LoRusso, A. Sekulic, J. Sosman, W. Liang +43 more
2021PLoS ONE4 citations Open access
Semantic Scholar
A Parametric Meta-Analysis
Chang Yu, D. Zelterman
2019Statistics in Medicine4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Deveaux×8
Invite
M. Deveaux — researcher profile on SciRah
K. Politi×6
Invite
K. Politi — researcher profile on SciRah
S. Gettinger×6
Invite
S. Gettinger — researcher profile on SciRah
J. Sweasy×6
Invite
J. Sweasy — researcher profile on SciRah

×5

Invite

S. Goldberg — researcher profile on SciRah

Invite

J. Weidhaas — researcher profile on SciRah

Yanhong Deng×4

Invite

Yanhong Deng — researcher profile on SciRah

T. Paranjape×4

Invite

T. Paranjape — researcher profile on SciRah

Invite

F. Slack — researcher profile on SciRah

Invite

D. Rimm — researcher profile on SciRah

Invite

C. Hatzis — researcher profile on SciRah

Invite

R. Herbst — researcher profile on SciRah